Elizabeth E. Reed, Chief Legal Officer and GC at Travere Therapeutics, Inc. (TVTX), sold 20,000 shares at $28.09 ($562K) on 2026-03-16, disclosed to the SEC on 2026-03-18.
Scheduled sale ($562k) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.09 | 10,000 | $281K | 50.0% |
| 2 | $28.09 | 10,000 | $281K | 50.0% |
| Total | $28.09 avg | 20,000 | $562K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-02-19 | $557K | — | Filing → |